nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—hypertension—type 2 diabetes mellitus	0.749	1	CtDrD
Bendroflumethiazide—KCNMA1—artery—type 2 diabetes mellitus	0.0032	0.0768	CbGeAlD
Bendroflumethiazide—CA1—nerve—type 2 diabetes mellitus	0.00241	0.0579	CbGeAlD
Bendroflumethiazide—CA4—nerve—type 2 diabetes mellitus	0.00189	0.0452	CbGeAlD
Bendroflumethiazide—SLC12A3—nephron tubule—type 2 diabetes mellitus	0.00179	0.043	CbGeAlD
Bendroflumethiazide—TPMT—islet of Langerhans—type 2 diabetes mellitus	0.00165	0.0397	CbGeAlD
Bendroflumethiazide—SLC12A3—kidney—type 2 diabetes mellitus	0.00157	0.0378	CbGeAlD
Bendroflumethiazide—KCNMA1—islet of Langerhans—type 2 diabetes mellitus	0.00154	0.0369	CbGeAlD
Bendroflumethiazide—SLC12A3—cortex of kidney—type 2 diabetes mellitus	0.00153	0.0368	CbGeAlD
Bendroflumethiazide—TPMT—retina—type 2 diabetes mellitus	0.00141	0.0339	CbGeAlD
Bendroflumethiazide—TPMT—nephron tubule—type 2 diabetes mellitus	0.00133	0.0319	CbGeAlD
Bendroflumethiazide—KCNMA1—retina—type 2 diabetes mellitus	0.00132	0.0316	CbGeAlD
Bendroflumethiazide—TPMT—kidney—type 2 diabetes mellitus	0.00117	0.0281	CbGeAlD
Bendroflumethiazide—TPMT—pancreas—type 2 diabetes mellitus	0.00116	0.0279	CbGeAlD
Bendroflumethiazide—TPMT—cortex of kidney—type 2 diabetes mellitus	0.00114	0.0273	CbGeAlD
Bendroflumethiazide—KCNMA1—cardiovascular system—type 2 diabetes mellitus	0.00111	0.0267	CbGeAlD
Bendroflumethiazide—KCNMA1—pancreas—type 2 diabetes mellitus	0.00108	0.0259	CbGeAlD
Bendroflumethiazide—TPMT—adipose tissue—type 2 diabetes mellitus	0.00105	0.0253	CbGeAlD
Bendroflumethiazide—KCNMA1—adipose tissue—type 2 diabetes mellitus	0.000981	0.0235	CbGeAlD
Bendroflumethiazide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000914	0.0219	CbGeAlD
Bendroflumethiazide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000845	0.0203	CbGeAlD
Bendroflumethiazide—CA1—kidney—type 2 diabetes mellitus	0.000827	0.0198	CbGeAlD
Bendroflumethiazide—CA1—pancreas—type 2 diabetes mellitus	0.000822	0.0197	CbGeAlD
Bendroflumethiazide—Diabetes mellitus—Bromocriptine—type 2 diabetes mellitus	0.00081	0.00628	CcSEcCtD
Bendroflumethiazide—Blood disorder—Metformin—type 2 diabetes mellitus	0.000798	0.00619	CcSEcCtD
Bendroflumethiazide—Drug interaction—Valsartan—type 2 diabetes mellitus	0.000789	0.00612	CcSEcCtD
Bendroflumethiazide—Drug interaction—Orlistat—type 2 diabetes mellitus	0.00078	0.00605	CcSEcCtD
Bendroflumethiazide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000757	0.0182	CbGeAlD
Bendroflumethiazide—CA1—adipose tissue—type 2 diabetes mellitus	0.000745	0.0179	CbGeAlD
Bendroflumethiazide—TPMT—liver—type 2 diabetes mellitus	0.00074	0.0177	CbGeAlD
Bendroflumethiazide—CA4—nephron tubule—type 2 diabetes mellitus	0.000736	0.0176	CbGeAlD
Bendroflumethiazide—Urine output increased—Gliclazide—type 2 diabetes mellitus	0.000721	0.00559	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Glyburide—type 2 diabetes mellitus	0.00072	0.00558	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Sitagliptin—type 2 diabetes mellitus	0.000711	0.00551	CcSEcCtD
Bendroflumethiazide—KCNMA1—liver—type 2 diabetes mellitus	0.000688	0.0165	CbGeAlD
Bendroflumethiazide—Drug interaction—Irbesartan—type 2 diabetes mellitus	0.000678	0.00526	CcSEcCtD
Bendroflumethiazide—Gout—Irbesartan—type 2 diabetes mellitus	0.000674	0.00522	CcSEcCtD
Bendroflumethiazide—Purpura—Glyburide—type 2 diabetes mellitus	0.000668	0.00518	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Tolbutamide—type 2 diabetes mellitus	0.000667	0.00517	CcSEcCtD
Bendroflumethiazide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000661	0.0158	CbGeAlD
Bendroflumethiazide—Pancreatitis—Sitagliptin—type 2 diabetes mellitus	0.00066	0.00512	CcSEcCtD
Bendroflumethiazide—Polyuria—Gliclazide—type 2 diabetes mellitus	0.000659	0.00511	CcSEcCtD
Bendroflumethiazide—Urine output increased—Orlistat—type 2 diabetes mellitus	0.000654	0.00507	CcSEcCtD
Bendroflumethiazide—Constipation—Miglitol—type 2 diabetes mellitus	0.000648	0.00503	CcSEcCtD
Bendroflumethiazide—CA2—retina—type 2 diabetes mellitus	0.000648	0.0155	CbGeAlD
Bendroflumethiazide—CA4—kidney—type 2 diabetes mellitus	0.000646	0.0155	CbGeAlD
Bendroflumethiazide—Orthostatic hypotension—Bromocriptine—type 2 diabetes mellitus	0.000644	0.00499	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Pioglitazone—type 2 diabetes mellitus	0.000638	0.00495	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Bromocriptine—type 2 diabetes mellitus	0.000635	0.00492	CcSEcCtD
Bendroflumethiazide—Gout—Losartan—type 2 diabetes mellitus	0.000634	0.00492	CcSEcCtD
Bendroflumethiazide—CA4—cortex of kidney—type 2 diabetes mellitus	0.00063	0.0151	CbGeAlD
Bendroflumethiazide—Erectile dysfunction—Sitagliptin—type 2 diabetes mellitus	0.00062	0.00481	CcSEcCtD
Bendroflumethiazide—CA2—nephron tubule—type 2 diabetes mellitus	0.00061	0.0146	CbGeAlD
Bendroflumethiazide—Thirst—Gliclazide—type 2 diabetes mellitus	0.000608	0.00471	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	0.000607	0.00471	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	0.000607	0.00471	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Orlistat—type 2 diabetes mellitus	0.000604	0.00468	CcSEcCtD
Bendroflumethiazide—Polyuria—Orlistat—type 2 diabetes mellitus	0.000598	0.00464	CcSEcCtD
Bendroflumethiazide—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.000591	0.00458	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	0.000583	0.00452	CcSEcCtD
Bendroflumethiazide—CA4—adipose tissue—type 2 diabetes mellitus	0.000583	0.014	CbGeAlD
Bendroflumethiazide—Thirst—Orlistat—type 2 diabetes mellitus	0.000552	0.00428	CcSEcCtD
Bendroflumethiazide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000548	0.0131	CbGeAlD
Bendroflumethiazide—Drug interaction—Ramipril—type 2 diabetes mellitus	0.000547	0.00424	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Glyburide—type 2 diabetes mellitus	0.000546	0.00423	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.000539	0.00418	CcSEcCtD
Bendroflumethiazide—CA2—kidney—type 2 diabetes mellitus	0.000536	0.0129	CbGeAlD
Bendroflumethiazide—CA2—pancreas—type 2 diabetes mellitus	0.000532	0.0128	CbGeAlD
Bendroflumethiazide—Diabetes mellitus—Irbesartan—type 2 diabetes mellitus	0.000525	0.00407	CcSEcCtD
Bendroflumethiazide—Constipation—Linagliptin—type 2 diabetes mellitus	0.000525	0.00407	CcSEcCtD
Bendroflumethiazide—CA1—liver—type 2 diabetes mellitus	0.000523	0.0125	CbGeAlD
Bendroflumethiazide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000522	0.0125	CbGeAlD
Bendroflumethiazide—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000519	0.00402	CcSEcCtD
Bendroflumethiazide—Constipation—Acarbose—type 2 diabetes mellitus	0.00051	0.00395	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Losartan—type 2 diabetes mellitus	0.000494	0.00383	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.000487	0.00378	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Valsartan—type 2 diabetes mellitus	0.000485	0.00376	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Glipizide—type 2 diabetes mellitus	0.000485	0.00376	CcSEcCtD
Bendroflumethiazide—CA2—adipose tissue—type 2 diabetes mellitus	0.000483	0.0116	CbGeAlD
Bendroflumethiazide—Vascular purpura—Losartan—type 2 diabetes mellitus	0.000481	0.00373	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Valsartan—type 2 diabetes mellitus	0.000479	0.00371	CcSEcCtD
Bendroflumethiazide—Rash—Miglitol—type 2 diabetes mellitus	0.000478	0.00371	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Orlistat—type 2 diabetes mellitus	0.000478	0.00371	CcSEcCtD
Bendroflumethiazide—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000478	0.0037	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Orlistat—type 2 diabetes mellitus	0.000473	0.00367	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Pioglitazone—type 2 diabetes mellitus	0.000464	0.0036	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Gliclazide—type 2 diabetes mellitus	0.000461	0.00357	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.00046	0.00357	CcSEcCtD
Bendroflumethiazide—Urine output increased—Ramipril—type 2 diabetes mellitus	0.000459	0.00356	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Sitagliptin—type 2 diabetes mellitus	0.000451	0.0035	CcSEcCtD
Bendroflumethiazide—Nausea—Miglitol—type 2 diabetes mellitus	0.00045	0.00349	CcSEcCtD
Bendroflumethiazide—Purpura—Losartan—type 2 diabetes mellitus	0.000446	0.00346	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Orlistat—type 2 diabetes mellitus	0.000445	0.00345	CcSEcCtD
Bendroflumethiazide—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000445	0.00345	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Metformin—type 2 diabetes mellitus	0.000436	0.00338	CcSEcCtD
Bendroflumethiazide—Rash—Tolbutamide—type 2 diabetes mellitus	0.00043	0.00333	CcSEcCtD
Bendroflumethiazide—Constipation—Repaglinide—type 2 diabetes mellitus	0.000425	0.0033	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000424	0.00329	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Valsartan—type 2 diabetes mellitus	0.000423	0.00328	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00042	0.00326	CcSEcCtD
Bendroflumethiazide—Polyuria—Ramipril—type 2 diabetes mellitus	0.00042	0.00325	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.000417	0.00323	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.000416	0.00322	CcSEcCtD
Bendroflumethiazide—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000412	0.0032	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Ramipril—type 2 diabetes mellitus	0.000412	0.00319	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Irbesartan—type 2 diabetes mellitus	0.000411	0.00319	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Metformin—type 2 diabetes mellitus	0.00041	0.00318	CcSEcCtD
Bendroflumethiazide—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00041	0.00318	CcSEcCtD
Bendroflumethiazide—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00041	0.00318	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.000408	0.00316	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000408	0.00316	CcSEcCtD
Bendroflumethiazide—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000405	0.00314	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000403	0.00312	CcSEcCtD
Bendroflumethiazide—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000402	0.00312	CcSEcCtD
Bendroflumethiazide—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000394	0.00306	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000393	0.00305	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000393	0.00304	CcSEcCtD
Bendroflumethiazide—Anorexia—Glipizide—type 2 diabetes mellitus	0.000392	0.00304	CcSEcCtD
Bendroflumethiazide—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000391	0.00303	CcSEcCtD
Bendroflumethiazide—Rash—Tolazamide—type 2 diabetes mellitus	0.000391	0.00303	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Losartan—type 2 diabetes mellitus	0.000387	0.003	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Irbesartan—type 2 diabetes mellitus	0.000387	0.003	CcSEcCtD
Bendroflumethiazide—Rash—Linagliptin—type 2 diabetes mellitus	0.000387	0.003	CcSEcCtD
Bendroflumethiazide—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000387	0.003	CcSEcCtD
Bendroflumethiazide—Purpura—Ramipril—type 2 diabetes mellitus	0.000382	0.00297	CcSEcCtD
Bendroflumethiazide—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00038	0.00295	CcSEcCtD
Bendroflumethiazide—Vomiting—Acarbose—type 2 diabetes mellitus	0.000379	0.00294	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000376	0.00291	CcSEcCtD
Bendroflumethiazide—Rash—Acarbose—type 2 diabetes mellitus	0.000376	0.00291	CcSEcCtD
Bendroflumethiazide—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000375	0.00291	CcSEcCtD
Bendroflumethiazide—Nausea—Tolazamide—type 2 diabetes mellitus	0.000368	0.00286	CcSEcCtD
Bendroflumethiazide—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000368	0.00286	CcSEcCtD
Bendroflumethiazide—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000366	0.00284	CcSEcCtD
Bendroflumethiazide—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000365	0.00283	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Losartan—type 2 diabetes mellitus	0.000364	0.00282	CcSEcCtD
Bendroflumethiazide—Rash—Nateglinide—type 2 diabetes mellitus	0.000362	0.00281	CcSEcCtD
Bendroflumethiazide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000362	0.00281	CcSEcCtD
Bendroflumethiazide—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000359	0.00278	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000358	0.00277	CcSEcCtD
Bendroflumethiazide—Nausea—Acarbose—type 2 diabetes mellitus	0.000354	0.00274	CcSEcCtD
Bendroflumethiazide—Constipation—Glipizide—type 2 diabetes mellitus	0.000352	0.00273	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000342	0.00265	CcSEcCtD
Bendroflumethiazide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000341	0.00265	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00034	0.00264	CcSEcCtD
Bendroflumethiazide—CA2—liver—type 2 diabetes mellitus	0.000339	0.00813	CbGeAlD
Bendroflumethiazide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000337	0.00261	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000337	0.00261	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000334	0.00259	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000333	0.00258	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.000332	0.00257	CcSEcCtD
Bendroflumethiazide—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00033	0.00256	CcSEcCtD
Bendroflumethiazide—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000327	0.00254	CcSEcCtD
Bendroflumethiazide—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000324	0.00251	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000322	0.00249	CcSEcCtD
Bendroflumethiazide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000316	0.00245	CcSEcCtD
Bendroflumethiazide—Rash—Repaglinide—type 2 diabetes mellitus	0.000314	0.00243	CcSEcCtD
Bendroflumethiazide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000313	0.00243	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.000312	0.00242	CcSEcCtD
Bendroflumethiazide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000311	0.00241	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00031	0.0024	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000308	0.00239	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000304	0.00236	CcSEcCtD
Bendroflumethiazide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000302	0.00234	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000301	0.00233	CcSEcCtD
Bendroflumethiazide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000296	0.0023	CcSEcCtD
Bendroflumethiazide—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000296	0.0023	CcSEcCtD
Bendroflumethiazide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000296	0.0023	CcSEcCtD
Bendroflumethiazide—Hypotension—Glyburide—type 2 diabetes mellitus	0.000296	0.00229	CcSEcCtD
Bendroflumethiazide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000295	0.00229	CcSEcCtD
Bendroflumethiazide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000295	0.00229	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000293	0.00227	CcSEcCtD
Bendroflumethiazide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000283	0.00219	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000282	0.00218	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00028	0.00217	CcSEcCtD
Bendroflumethiazide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000279	0.00216	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000278	0.00216	CcSEcCtD
Bendroflumethiazide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000275	0.00214	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000275	0.00213	CcSEcCtD
Bendroflumethiazide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000275	0.00213	CcSEcCtD
Bendroflumethiazide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000272	0.00211	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00027	0.00209	CcSEcCtD
Bendroflumethiazide—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000266	0.00206	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000264	0.00205	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000263	0.00204	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000262	0.00203	CcSEcCtD
Bendroflumethiazide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000262	0.00203	CcSEcCtD
Bendroflumethiazide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000261	0.00202	CcSEcCtD
Bendroflumethiazide—Rash—Glipizide—type 2 diabetes mellitus	0.000259	0.00201	CcSEcCtD
Bendroflumethiazide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000259	0.00201	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000256	0.00198	CcSEcCtD
Bendroflumethiazide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000254	0.00197	CcSEcCtD
Bendroflumethiazide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00196	CcSEcCtD
Bendroflumethiazide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000249	0.00193	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000249	0.00193	CcSEcCtD
Bendroflumethiazide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000249	0.00193	CcSEcCtD
Bendroflumethiazide—Nausea—Glipizide—type 2 diabetes mellitus	0.000244	0.00189	CcSEcCtD
Bendroflumethiazide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000244	0.00189	CcSEcCtD
Bendroflumethiazide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000244	0.00189	CcSEcCtD
Bendroflumethiazide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000243	0.00189	CcSEcCtD
Bendroflumethiazide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000243	0.00189	CcSEcCtD
Bendroflumethiazide—Rash—Glimepiride—type 2 diabetes mellitus	0.000242	0.00188	CcSEcCtD
Bendroflumethiazide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000242	0.00188	CcSEcCtD
Bendroflumethiazide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00187	CcSEcCtD
Bendroflumethiazide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00187	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000237	0.00184	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000233	0.00181	CcSEcCtD
Bendroflumethiazide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00178	CcSEcCtD
Bendroflumethiazide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000228	0.00177	CcSEcCtD
Bendroflumethiazide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00176	CcSEcCtD
Bendroflumethiazide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000227	0.00176	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000227	0.00176	CcSEcCtD
Bendroflumethiazide—Anorexia—Metformin—type 2 diabetes mellitus	0.000227	0.00176	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000224	0.00174	CcSEcCtD
Bendroflumethiazide—Constipation—Valsartan—type 2 diabetes mellitus	0.000223	0.00173	CcSEcCtD
Bendroflumethiazide—Hypotension—Metformin—type 2 diabetes mellitus	0.000222	0.00172	CcSEcCtD
Bendroflumethiazide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00022	0.00171	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00022	0.0017	CcSEcCtD
Bendroflumethiazide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00169	CcSEcCtD
Bendroflumethiazide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00169	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000217	0.00168	CcSEcCtD
Bendroflumethiazide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000214	0.00166	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000213	0.00165	CcSEcCtD
Bendroflumethiazide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00021	0.00163	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000207	0.0016	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000207	0.0016	CcSEcCtD
Bendroflumethiazide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000206	0.0016	CcSEcCtD
Bendroflumethiazide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000204	0.00158	CcSEcCtD
Bendroflumethiazide—Constipation—Metformin—type 2 diabetes mellitus	0.000203	0.00158	CcSEcCtD
Bendroflumethiazide—Anorexia—Losartan—type 2 diabetes mellitus	0.000201	0.00156	CcSEcCtD
Bendroflumethiazide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000201	0.00156	CcSEcCtD
Bendroflumethiazide—Rash—Glyburide—type 2 diabetes mellitus	0.0002	0.00155	CcSEcCtD
Bendroflumethiazide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000199	0.00155	CcSEcCtD
Bendroflumethiazide—Hypotension—Losartan—type 2 diabetes mellitus	0.000197	0.00153	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000195	0.00151	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000195	0.00151	CcSEcCtD
Bendroflumethiazide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000192	0.00149	CcSEcCtD
Bendroflumethiazide—Nausea—Glyburide—type 2 diabetes mellitus	0.000188	0.00146	CcSEcCtD
Bendroflumethiazide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000188	0.00146	CcSEcCtD
Bendroflumethiazide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000187	0.00145	CcSEcCtD
Bendroflumethiazide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000185	0.00144	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000184	0.00142	CcSEcCtD
Bendroflumethiazide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000181	0.0014	CcSEcCtD
Bendroflumethiazide—Constipation—Losartan—type 2 diabetes mellitus	0.000181	0.0014	CcSEcCtD
Bendroflumethiazide—Rash—Gliclazide—type 2 diabetes mellitus	0.000179	0.00139	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000179	0.00139	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000179	0.00139	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000177	0.00138	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000177	0.00137	CcSEcCtD
Bendroflumethiazide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000173	0.00134	CcSEcCtD
Bendroflumethiazide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000173	0.00134	CcSEcCtD
Bendroflumethiazide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000171	0.00132	CcSEcCtD
Bendroflumethiazide—Asthenia—Metformin—type 2 diabetes mellitus	0.000171	0.00132	CcSEcCtD
Bendroflumethiazide—Hypotension—Ramipril—type 2 diabetes mellitus	0.000169	0.00131	CcSEcCtD
Bendroflumethiazide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000169	0.00131	CcSEcCtD
Bendroflumethiazide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000166	0.00129	CcSEcCtD
Bendroflumethiazide—Rash—Valsartan—type 2 diabetes mellitus	0.000165	0.00128	CcSEcCtD
Bendroflumethiazide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000165	0.00128	CcSEcCtD
Bendroflumethiazide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000164	0.00127	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000163	0.00126	CcSEcCtD
Bendroflumethiazide—Rash—Orlistat—type 2 diabetes mellitus	0.000163	0.00126	CcSEcCtD
Bendroflumethiazide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000163	0.00126	CcSEcCtD
Bendroflumethiazide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000161	0.00125	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000157	0.00122	CcSEcCtD
Bendroflumethiazide—Dizziness—Metformin—type 2 diabetes mellitus	0.000157	0.00122	CcSEcCtD
Bendroflumethiazide—Nausea—Valsartan—type 2 diabetes mellitus	0.000155	0.0012	CcSEcCtD
Bendroflumethiazide—Constipation—Ramipril—type 2 diabetes mellitus	0.000155	0.0012	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000154	0.00119	CcSEcCtD
Bendroflumethiazide—Nausea—Orlistat—type 2 diabetes mellitus	0.000153	0.00119	CcSEcCtD
Bendroflumethiazide—Asthenia—Losartan—type 2 diabetes mellitus	0.000152	0.00118	CcSEcCtD
Bendroflumethiazide—Vomiting—Metformin—type 2 diabetes mellitus	0.000151	0.00117	CcSEcCtD
Bendroflumethiazide—Rash—Metformin—type 2 diabetes mellitus	0.00015	0.00116	CcSEcCtD
Bendroflumethiazide—Dermatitis—Metformin—type 2 diabetes mellitus	0.00015	0.00116	CcSEcCtD
Bendroflumethiazide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000148	0.00115	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000145	0.00112	CcSEcCtD
Bendroflumethiazide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000143	0.00111	CcSEcCtD
Bendroflumethiazide—Rash—Irbesartan—type 2 diabetes mellitus	0.000142	0.0011	CcSEcCtD
Bendroflumethiazide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000141	0.0011	CcSEcCtD
Bendroflumethiazide—Nausea—Metformin—type 2 diabetes mellitus	0.000141	0.0011	CcSEcCtD
Bendroflumethiazide—Dizziness—Losartan—type 2 diabetes mellitus	0.00014	0.00108	CcSEcCtD
Bendroflumethiazide—Vomiting—Losartan—type 2 diabetes mellitus	0.000134	0.00104	CcSEcCtD
Bendroflumethiazide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000133	0.00103	CcSEcCtD
Bendroflumethiazide—Rash—Losartan—type 2 diabetes mellitus	0.000133	0.00103	CcSEcCtD
Bendroflumethiazide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000133	0.00103	CcSEcCtD
Bendroflumethiazide—Asthenia—Ramipril—type 2 diabetes mellitus	0.00013	0.00101	CcSEcCtD
Bendroflumethiazide—Nausea—Losartan—type 2 diabetes mellitus	0.000125	0.000973	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000124	0.000961	CcSEcCtD
Bendroflumethiazide—Dizziness—Ramipril—type 2 diabetes mellitus	0.00012	0.000929	CcSEcCtD
Bendroflumethiazide—Vomiting—Ramipril—type 2 diabetes mellitus	0.000115	0.000893	CcSEcCtD
Bendroflumethiazide—Rash—Ramipril—type 2 diabetes mellitus	0.000114	0.000886	CcSEcCtD
Bendroflumethiazide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000114	0.000885	CcSEcCtD
Bendroflumethiazide—Nausea—Ramipril—type 2 diabetes mellitus	0.000108	0.000834	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—CBS—type 2 diabetes mellitus	5.22e-05	0.000654	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—STAR—type 2 diabetes mellitus	5.22e-05	0.000654	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCC8—type 2 diabetes mellitus	5.22e-05	0.000654	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSD17B3—type 2 diabetes mellitus	5.22e-05	0.000654	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA6—type 2 diabetes mellitus	5.15e-05	0.000645	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.07e-05	0.000634	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—UCP3—type 2 diabetes mellitus	5.07e-05	0.000634	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—UCP2—type 2 diabetes mellitus	5.07e-05	0.000634	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.06e-05	0.000633	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—COX2—type 2 diabetes mellitus	5.03e-05	0.000629	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC5A2—type 2 diabetes mellitus	5.03e-05	0.000629	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CBS—type 2 diabetes mellitus	5.01e-05	0.000627	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCC8—type 2 diabetes mellitus	5.01e-05	0.000627	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC2A2—type 2 diabetes mellitus	4.96e-05	0.00062	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA6—type 2 diabetes mellitus	4.94e-05	0.000618	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MMP1—type 2 diabetes mellitus	4.9e-05	0.000613	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTR—type 2 diabetes mellitus	4.86e-05	0.000608	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—UCP2—type 2 diabetes mellitus	4.86e-05	0.000608	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CPT1A—type 2 diabetes mellitus	4.86e-05	0.000608	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—UCP3—type 2 diabetes mellitus	4.86e-05	0.000608	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSD11B1—type 2 diabetes mellitus	4.86e-05	0.000608	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC5A2—type 2 diabetes mellitus	4.82e-05	0.000603	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—COX2—type 2 diabetes mellitus	4.82e-05	0.000603	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PCK1—type 2 diabetes mellitus	4.76e-05	0.000596	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NAMPT—type 2 diabetes mellitus	4.76e-05	0.000596	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CALM1—type 2 diabetes mellitus	4.76e-05	0.000596	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA6—type 2 diabetes mellitus	4.74e-05	0.000593	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—LIPC—type 2 diabetes mellitus	4.73e-05	0.000592	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HBA1—type 2 diabetes mellitus	4.73e-05	0.000592	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GCK—type 2 diabetes mellitus	4.73e-05	0.000592	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP11A1—type 2 diabetes mellitus	4.7e-05	0.000588	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—APOA1—type 2 diabetes mellitus	4.69e-05	0.000587	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSD11B1—type 2 diabetes mellitus	4.66e-05	0.000583	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UCP2—type 2 diabetes mellitus	4.66e-05	0.000583	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UCP3—type 2 diabetes mellitus	4.66e-05	0.000583	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC9A1—type 2 diabetes mellitus	4.62e-05	0.000578	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PCK1—type 2 diabetes mellitus	4.57e-05	0.000571	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CETP—type 2 diabetes mellitus	4.57e-05	0.000571	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.57e-05	0.000571	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PRKCB—type 2 diabetes mellitus	4.47e-05	0.00056	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HK1—type 2 diabetes mellitus	4.46e-05	0.000558	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS2—type 2 diabetes mellitus	4.42e-05	0.000553	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PCK1—type 2 diabetes mellitus	4.38e-05	0.000548	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.31e-05	0.000539	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GCKR—type 2 diabetes mellitus	4.31e-05	0.000539	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—LPA—type 2 diabetes mellitus	4.31e-05	0.000539	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.31e-05	0.000539	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.28e-05	0.000536	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HK1—type 2 diabetes mellitus	4.28e-05	0.000535	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PSMD6—type 2 diabetes mellitus	4.25e-05	0.000531	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SNAP25—type 2 diabetes mellitus	4.25e-05	0.000531	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SREBF1—type 2 diabetes mellitus	4.25e-05	0.000531	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CTGF—type 2 diabetes mellitus	4.17e-05	0.000521	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSD3B2—type 2 diabetes mellitus	4.13e-05	0.000517	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—LPA—type 2 diabetes mellitus	4.13e-05	0.000517	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—KCNJ11—type 2 diabetes mellitus	4.13e-05	0.000517	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GCKR—type 2 diabetes mellitus	4.13e-05	0.000517	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALDOB—type 2 diabetes mellitus	4.13e-05	0.000517	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HMGCR—type 2 diabetes mellitus	4.13e-05	0.000517	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HK1—type 2 diabetes mellitus	4.1e-05	0.000513	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADRA2A—type 2 diabetes mellitus	4.04e-05	0.000506	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—LPA—type 2 diabetes mellitus	3.96e-05	0.000495	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.96e-05	0.000495	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GCKR—type 2 diabetes mellitus	3.96e-05	0.000495	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALDOB—type 2 diabetes mellitus	3.96e-05	0.000495	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.96e-05	0.000495	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF1—type 2 diabetes mellitus	3.92e-05	0.00049	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT2—type 2 diabetes mellitus	3.92e-05	0.00049	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2E1—type 2 diabetes mellitus	3.88e-05	0.000486	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1A2—type 2 diabetes mellitus	3.84e-05	0.00048	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GLP1R—type 2 diabetes mellitus	3.84e-05	0.00048	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC2A1—type 2 diabetes mellitus	3.84e-05	0.00048	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALDOB—type 2 diabetes mellitus	3.8e-05	0.000475	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP3A4—type 2 diabetes mellitus	3.74e-05	0.000468	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SERPINE1—type 2 diabetes mellitus	3.72e-05	0.000466	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ALB—type 2 diabetes mellitus	3.72e-05	0.000465	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—type 2 diabetes mellitus	3.71e-05	0.000464	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GCG—type 2 diabetes mellitus	3.68e-05	0.00046	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC2A4—type 2 diabetes mellitus	3.68e-05	0.00046	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GLP1R—type 2 diabetes mellitus	3.68e-05	0.00046	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.58e-05	0.000448	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3R1—type 2 diabetes mellitus	3.55e-05	0.000445	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS3—type 2 diabetes mellitus	3.55e-05	0.000445	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GLP1R—type 2 diabetes mellitus	3.53e-05	0.000441	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CPT1A—type 2 diabetes mellitus	3.51e-05	0.000439	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTR—type 2 diabetes mellitus	3.51e-05	0.000439	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NAMPT—type 2 diabetes mellitus	3.44e-05	0.000431	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.44e-05	0.00043	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—LIPC—type 2 diabetes mellitus	3.42e-05	0.000428	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HBA1—type 2 diabetes mellitus	3.42e-05	0.000428	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GCK—type 2 diabetes mellitus	3.42e-05	0.000428	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.4e-05	0.000425	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.39e-05	0.000424	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTR—type 2 diabetes mellitus	3.37e-05	0.000421	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CPT1A—type 2 diabetes mellitus	3.37e-05	0.000421	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.34e-05	0.000418	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NAMPT—type 2 diabetes mellitus	3.3e-05	0.000413	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CETP—type 2 diabetes mellitus	3.3e-05	0.000413	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.29e-05	0.000412	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GCK—type 2 diabetes mellitus	3.28e-05	0.00041	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HBA1—type 2 diabetes mellitus	3.28e-05	0.00041	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—LIPC—type 2 diabetes mellitus	3.28e-05	0.00041	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.26e-05	0.000408	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CPT1A—type 2 diabetes mellitus	3.23e-05	0.000404	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTR—type 2 diabetes mellitus	3.23e-05	0.000404	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.2e-05	0.000401	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GNB3—type 2 diabetes mellitus	3.17e-05	0.000397	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.17e-05	0.000397	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NAMPT—type 2 diabetes mellitus	3.17e-05	0.000396	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CETP—type 2 diabetes mellitus	3.17e-05	0.000396	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HMOX1—type 2 diabetes mellitus	3.16e-05	0.000395	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—LIPC—type 2 diabetes mellitus	3.15e-05	0.000393	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HBA1—type 2 diabetes mellitus	3.15e-05	0.000393	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GCK—type 2 diabetes mellitus	3.15e-05	0.000393	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.13e-05	0.000391	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CAT—type 2 diabetes mellitus	3.12e-05	0.00039	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.07e-05	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PSMD6—type 2 diabetes mellitus	3.07e-05	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SNAP25—type 2 diabetes mellitus	3.07e-05	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SREBF1—type 2 diabetes mellitus	3.07e-05	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CETP—type 2 diabetes mellitus	3.03e-05	0.00038	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—APOB—type 2 diabetes mellitus	3.03e-05	0.000378	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CTGF—type 2 diabetes mellitus	3.01e-05	0.000377	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HMGCR—type 2 diabetes mellitus	2.99e-05	0.000374	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PSMD6—type 2 diabetes mellitus	2.94e-05	0.000368	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SREBF1—type 2 diabetes mellitus	2.94e-05	0.000368	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SNAP25—type 2 diabetes mellitus	2.94e-05	0.000368	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—type 2 diabetes mellitus	2.94e-05	0.000368	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.92e-05	0.000366	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CTGF—type 2 diabetes mellitus	2.89e-05	0.000361	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—LPL—type 2 diabetes mellitus	2.89e-05	0.000361	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HMGCR—type 2 diabetes mellitus	2.86e-05	0.000358	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADCY5—type 2 diabetes mellitus	2.83e-05	0.000354	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PSMD6—type 2 diabetes mellitus	2.82e-05	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SNAP25—type 2 diabetes mellitus	2.82e-05	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SREBF1—type 2 diabetes mellitus	2.82e-05	0.000353	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPX1—type 2 diabetes mellitus	2.82e-05	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.81e-05	0.000351	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.8e-05	0.00035	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.78e-05	0.000347	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.78e-05	0.000347	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CTGF—type 2 diabetes mellitus	2.77e-05	0.000346	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HMGCR—type 2 diabetes mellitus	2.74e-05	0.000343	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CD36—type 2 diabetes mellitus	2.74e-05	0.000343	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPP2CA—type 2 diabetes mellitus	2.71e-05	0.000339	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP3A4—type 2 diabetes mellitus	2.71e-05	0.000339	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.69e-05	0.000337	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.69e-05	0.000336	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1A2—type 2 diabetes mellitus	2.66e-05	0.000333	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.66e-05	0.000333	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GCG—type 2 diabetes mellitus	2.66e-05	0.000333	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.66e-05	0.000333	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SRC—type 2 diabetes mellitus	2.63e-05	0.000329	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—type 2 diabetes mellitus	2.6e-05	0.000325	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.6e-05	0.000325	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.58e-05	0.000323	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—type 2 diabetes mellitus	2.56e-05	0.00032	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.55e-05	0.000319	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GCG—type 2 diabetes mellitus	2.55e-05	0.000319	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.55e-05	0.000319	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARA—type 2 diabetes mellitus	2.55e-05	0.000319	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.55e-05	0.000319	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.49e-05	0.000311	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AGT—type 2 diabetes mellitus	2.47e-05	0.000309	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.45e-05	0.000306	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GCG—type 2 diabetes mellitus	2.45e-05	0.000306	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CALM1—type 2 diabetes mellitus	2.43e-05	0.000304	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—APOE—type 2 diabetes mellitus	2.42e-05	0.000303	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—APOA1—type 2 diabetes mellitus	2.39e-05	0.000299	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TGFB1—type 2 diabetes mellitus	2.35e-05	0.000294	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GNB3—type 2 diabetes mellitus	2.29e-05	0.000287	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.29e-05	0.000287	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HMOX1—type 2 diabetes mellitus	2.28e-05	0.000286	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CAT—type 2 diabetes mellitus	2.25e-05	0.000282	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GNB3—type 2 diabetes mellitus	2.2e-05	0.000275	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.2e-05	0.000275	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HMOX1—type 2 diabetes mellitus	2.19e-05	0.000274	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—APOB—type 2 diabetes mellitus	2.19e-05	0.000274	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CAT—type 2 diabetes mellitus	2.16e-05	0.00027	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—type 2 diabetes mellitus	2.13e-05	0.000266	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARG—type 2 diabetes mellitus	2.11e-05	0.000264	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.11e-05	0.000264	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GNB3—type 2 diabetes mellitus	2.11e-05	0.000264	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HMOX1—type 2 diabetes mellitus	2.1e-05	0.000263	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—APOB—type 2 diabetes mellitus	2.1e-05	0.000262	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—LPL—type 2 diabetes mellitus	2.09e-05	0.000261	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CAT—type 2 diabetes mellitus	2.07e-05	0.000259	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—INS—type 2 diabetes mellitus	2.07e-05	0.000259	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADCY5—type 2 diabetes mellitus	2.04e-05	0.000256	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—type 2 diabetes mellitus	2.04e-05	0.000255	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX1—type 2 diabetes mellitus	2.04e-05	0.000255	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—APOB—type 2 diabetes mellitus	2.01e-05	0.000251	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—LPL—type 2 diabetes mellitus	2e-05	0.00025	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CD36—type 2 diabetes mellitus	1.98e-05	0.000248	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADCY5—type 2 diabetes mellitus	1.96e-05	0.000245	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.96e-05	0.000245	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—type 2 diabetes mellitus	1.96e-05	0.000245	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX1—type 2 diabetes mellitus	1.95e-05	0.000244	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—LPL—type 2 diabetes mellitus	1.92e-05	0.00024	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CD36—type 2 diabetes mellitus	1.9e-05	0.000238	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALB—type 2 diabetes mellitus	1.9e-05	0.000237	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—type 2 diabetes mellitus	1.88e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADCY5—type 2 diabetes mellitus	1.88e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.88e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX1—type 2 diabetes mellitus	1.87e-05	0.000234	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARA—type 2 diabetes mellitus	1.84e-05	0.000231	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CD36—type 2 diabetes mellitus	1.82e-05	0.000228	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-05	0.000227	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-05	0.000227	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—type 2 diabetes mellitus	1.8e-05	0.000226	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.8e-05	0.000225	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AGT—type 2 diabetes mellitus	1.79e-05	0.000223	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARA—type 2 diabetes mellitus	1.77e-05	0.000221	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CALM1—type 2 diabetes mellitus	1.76e-05	0.00022	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—APOE—type 2 diabetes mellitus	1.75e-05	0.000219	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	1.73e-05	0.000216	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	1.73e-05	0.000216	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AGT—type 2 diabetes mellitus	1.71e-05	0.000214	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARA—type 2 diabetes mellitus	1.7e-05	0.000212	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CALM1—type 2 diabetes mellitus	1.68e-05	0.000211	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—APOE—type 2 diabetes mellitus	1.68e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—APOA1—type 2 diabetes mellitus	1.66e-05	0.000208	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-05	0.000208	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AGT—type 2 diabetes mellitus	1.64e-05	0.000205	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—type 2 diabetes mellitus	1.63e-05	0.000204	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CALM1—type 2 diabetes mellitus	1.61e-05	0.000202	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—APOE—type 2 diabetes mellitus	1.61e-05	0.000201	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—APOA1—type 2 diabetes mellitus	1.59e-05	0.000199	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	1.52e-05	0.000191	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—INS—type 2 diabetes mellitus	1.5e-05	0.000187	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARG—type 2 diabetes mellitus	1.46e-05	0.000183	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—INS—type 2 diabetes mellitus	1.43e-05	0.000179	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-05	0.000175	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—INS—type 2 diabetes mellitus	1.37e-05	0.000172	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALB—type 2 diabetes mellitus	1.37e-05	0.000172	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALB—type 2 diabetes mellitus	1.31e-05	0.000164	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	1.31e-05	0.000164	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.31e-05	0.000164	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALB—type 2 diabetes mellitus	1.26e-05	0.000158	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.26e-05	0.000157	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	1.26e-05	0.000157	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.21e-05	0.000151	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	1.21e-05	0.000151	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	1.2e-05	0.00015	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	1.15e-05	0.000144	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-05	0.000138	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—type 2 diabetes mellitus	8.34e-06	0.000104	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	6.03e-06	7.54e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	5.78e-06	7.23e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	5.54e-06	6.93e-05	CbGpPWpGaD
